UBS AG set a €125.00 ($145.35) price target on Bayer AG (FRA:BAYN) in a report released on Thursday morning, www.boersen-zeitung.de reports. The firm currently has a buy rating on the healthcare company’s stock.

Other research analysts also recently issued research reports about the company. J P Morgan Chase & Co set a €125.00 ($145.35) target price on Bayer AG and gave the company a buy rating in a research note on Monday, July 3rd. Baader Bank set a €120.00 ($139.53) target price on Bayer AG and gave the company a neutral rating in a research note on Monday, July 3rd. BNP Paribas set a €103.00 ($119.77) target price on Bayer AG and gave the company a neutral rating in a research note on Monday, July 3rd. Deutsche Bank AG set a €124.00 ($144.19) target price on Bayer AG and gave the company a buy rating in a research note on Monday, July 24th. Finally, Sanford C. Bernstein set a €125.00 ($145.35) target price on Bayer AG and gave the company a buy rating in a research note on Tuesday, April 18th. Nine research analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the company. Bayer AG currently has an average rating of Buy and a consensus price target of €120.27 ($139.85).

Bayer AG (BAYN) opened at 107.875 on Thursday. Bayer AG has a 12-month low of €85.72 and a 12-month high of €123.83. The stock has a market capitalization of €94.08 billion and a P/E ratio of 18.660. The stock has a 50 day moving average price of €115.43 and a 200-day moving average price of €110.25.

WARNING: “Bayer AG (BAYN) Given a €125.00 Price Target at UBS AG” was posted by Watch List News and is the property of of Watch List News. If you are accessing this article on another site, it was stolen and republished in violation of US & international copyright legislation. The correct version of this article can be viewed at https://www.watchlistnews.com/bayer-ag-bayn-given-a-125-00-price-target-at-ubs-ag/1463102.html.

About Bayer AG

.

Analyst Recommendations for Bayer AG (FRA:BAYN)

Receive News & Ratings for Bayer AG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bayer AG and related companies with Analyst Ratings Network's FREE daily email newsletter.